Fellbach – biosyn Arzneimittel GmbH celebrates 40 years of company history. Since 1984, the company has stood for pharmaceutical excellence, sound research, and the trust of physicians and patients worldwide.
Dr. Thomas Stiefel, co-founder and scientific head of biosyn, emphasizes the central role of research:
“From the very beginning, our goal was to open up new paths in medicine based on scientific evidence. With selenase®, we created a product that is now recognized internationally as the standard in selenium therapy. This development is the result of consistent research and our conviction that trace elements make an essential contribution to modern medicine – particularly in oncology, where selenium is increasingly used as part of complementary therapy.”
Ortwin Kottwitz, co-founder, highlights the company’s sense of responsibility:
“biosyn is more than a pharmaceutical manufacturer – we are a partner for physicians and patients. Research, responsibility, and ethical conduct have always been inseparably linked for us. The success of biosyn is based not only on innovations such as selenase® but also on the trust we have earned over four decades through quality and reliability. We are among the pioneers in implementing internationally recognized quality standards according to GMP (Good Manufacturing Practice).”
Pascal Voltzenlugel, CEO of biosyn, outlines the company’s future vision and explains the we care philosophy:
“40 years of biosyn mean both commitment and motivation. With We Care, we express our guiding principle: we care for people’s health, for the science that supports our products, and for our responsibility toward society and the environment. In the coming decades, we are determined to further advance trace element medicine and make a real difference in patients’ lives worldwide through innovative therapies.”
To mark the anniversary, biosyn invites long-standing partners from research, medicine, and society to a celebratory event in Fellbach. The occasion will not only look back on four decades of success but also focus on the future — with the clear goal of strengthening biosyn’s role as a pioneer in trace element therapy.
About biosyn Arzneimittel GmbH
biosyn Arzneimittel GmbH, headquartered in Fellbach near Stuttgart, is an internationally active pharmaceutical company specializing in the development, production, and distribution of trace element preparations, antioxidants, and innovative pharmaceuticals. With more than 40 years of experience, biosyn combines scientific excellence with the highest standards of pharmaceutical quality, responsibility, and sustainability.
